Karyomapping: A Rapid PGD Solution for Single-Gene Disorders

Illumina

The ability to decipher DNA sequences is providing new insights into human health and helping us enter a new era of genomes-based healthcare. Among the many areas benefiting from this increase in knowledge is reproductive health, particularly preimplantation genetic diagnosis (PGD). In PGD, embryos are assessed for a specific genetic condition before transfer into the uterus. The goal of PGD is to prevent couples with a known risk of transmitting an inherited genetic disorder of having children affected with that disorder. 

Find out more about karyomapping and PGD in this white paper, in association with our Founding Partner Illumina. To access this content simply fill out the contact form below. 

For more information on preimplementation genetic diagnosis, check out our webcast with Illumina on The Evolution of PGS: Next Generation Sequencing (NGS).

Your download should begin automatically.

Sharing your contact information with our white paper providers enables us to offer free white papers to our subscribers.

If you have any problems accessing this content please get in touch with liz@frontlinegenomics.com.

More on these topics